At Clinarmo, we understand that time and accuracy are of essence in an extremely regulated environment such as Drug Development. Our focus is on timely delivery for a project without compromising on quality. We ensure the quality by double programming each deliverable based on the specifications approved by our clients.
- Parallel, crossover and adaptive design studies from
Phase I to Phase IV in multiple therapeutic areas
- Regulatory submissions (NDA) to FDA, EMA and other agencies.
- Dataset derivations for statistical analysis (legacy) using SAS
- Raw or legacy datasets mapping to SDTM and define.xml/SDRG
generation using SAS and Pinnacle21.
- ADaM datasets derivation and define.xml/ADRG
generation using SAS and Pinnacle21.
- Generation of Tables/Listings/Figures using SAS.